Summary:
1. Agentic AI in healthcare is becoming more advanced, with life sciences companies investing heavily in its potential.
2. AI agents could generate significant economic value by 2028, with a focus on marketing processes in the pharmaceutical industry.
3. The implementation of agentic AI requires AI-ready data and a shift towards autonomous execution in marketing strategies.
Article:
Agentic AI in the healthcare industry is undergoing a transformation, moving beyond simple prompt responses to autonomously carrying out complex marketing tasks. Life sciences companies are placing their bets on the potential of AI agents to revolutionize their commercial strategies. A recent report by Capgemini Invent highlights the immense economic value that AI agents could generate by 2028, with a focus on revenue uplift and cost savings globally. In fact, 69% of executives are planning to deploy these agents in marketing processes by the end of the year.
The pharmaceutical sector, in particular, is facing challenges with limited face-time between sales representatives and healthcare professionals, a trend that has been exacerbated by the Covid-19 pandemic. The key challenge lies in making these interactions count with intelligence that is currently locked within data silos. Briggs Davidson, from Capgemini Invent, outlines a common scenario in pharma marketing where vital information is scattered across disparate systems, hindering sales reps from accessing crucial data before meeting with healthcare professionals.
The solution, according to Davidson, lies in deploying agentic AI in healthcare marketing to autonomously query, synthesize, and act on unified data. Unlike conversational AI, which responds to queries, agentic systems have the ability to independently execute multi-step tasks. This shift towards autonomous execution in marketing strategies is crucial for driving action and enhancing productivity.
Furthermore, the success of implementing agentic AI hinges on having AI-ready data that is standardized, accessible, complete, and trustworthy. This enables faster decision-making, personalization at scale, and a deeper understanding of marketing ROI. Davidson emphasizes the importance of marketing and IT alignment in identifying initial use cases and setting tangible outcomes to demonstrate the value of AI deployment.
As the healthcare industry continues to embrace agentic AI, the potential for these autonomous marketing agents to coordinate across various systems is promising. However, challenges around data governance and regulatory compliance remain. Whether this vision of autonomous marketing agents becomes standard practice by 2028 will determine if the industry can unlock the full potential of the projected $450 billion opportunity.
